Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • ASNR Foundation Special Collection
    • Most Impactful AJNR Articles
    • Photon-Counting CT
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • ASNR Foundation Special Collection
    • Most Impactful AJNR Articles
    • Photon-Counting CT
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR is seeking candidates for the AJNR Podcast Editor. Read the position description.

Research ArticleAdult Brain
Open Access

COVID-19 and Involvement of the Corpus Callosum: Potential Effect of the Cytokine Storm?

C. Rasmussen, I. Niculescu, S. Patel and A. Krishnan
American Journal of Neuroradiology September 2020, 41 (9) 1625-1628; DOI: https://doi.org/10.3174/ajnr.A6680
C. Rasmussen
aFrom the Departments of Diagnostic Radiology and Molecular Imaging (C.R., S.P., A.K.), and Internal Medicine (IN), Beaumont Health, Royal Oak, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C. Rasmussen
I. Niculescu
aFrom the Departments of Diagnostic Radiology and Molecular Imaging (C.R., S.P., A.K.), and Internal Medicine (IN), Beaumont Health, Royal Oak, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for I. Niculescu
S. Patel
aFrom the Departments of Diagnostic Radiology and Molecular Imaging (C.R., S.P., A.K.), and Internal Medicine (IN), Beaumont Health, Royal Oak, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S. Patel
A. Krishnan
aFrom the Departments of Diagnostic Radiology and Molecular Imaging (C.R., S.P., A.K.), and Internal Medicine (IN), Beaumont Health, Royal Oak, Michigan
bOakland University William Beaumont School of Medicine (A.K.), Rochester, Michigan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A. Krishnan
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Abstract

SUMMARY: Neurologic findings are being increasingly recognized in coronavirus disease 2019. We present a patient with a unique involvement of the corpus callosum that we relate to the cytokine storm seen in patients with Severe Acute Respiratory Syndrome coronavirus 2 infection. As the infection is increasingly seen around the world, recognition of these unique patterns may facilitate early identification of the progression of this disease and potentially facilitate appropriate management.

ABBREVIATIONS:

COVID-19
coronavirus disease 2019
SARS-Cov-2
Severe Acute Respiratory Syndrome coronavirus 2

Since December 2019, coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) has spread across the globe, infecting hundreds of thousands of patients. This virus, while known for causing severe respiratory illness, has been reported to affect multiple organ systems, including the central nervous system. Approximately 36% of patients with COVID-19 develop neurologic symptoms such as headache, altered mental status, and paresthesia.1 Also of note, these neurologic symptoms may be the first signs of illness and appear to affect more severely infected patients.2 We discuss an adult patient managed in the intensive care unit with unusual imaging findings centered in the corpus callosum and discuss the potential pathophysiology, including the relation to the cytokine storm.

Case Description

A 66-year-old woman with a medical history of pulmonary sarcoidosis, coronary artery disease, type 2 diabetes, hypertension, and hyperlipidemia presented to the emergency department with a 2-day history of fevers, chills, and severe headache with associated blurry vision, which progressed to severe shortness of breath and chest pain. On admission, the patient's labs were remarkable for hyperglycemia, mild normocytic anemia, acute kidney injury, lymphopenia (0.4 bil/L), and elevated C-reactive protein (130 mg/L) and ferritin (630 mg/mL) levels. The patient subsequently tested positive for SARS-CoV-2 from a nasopharyngeal swab and was started on azithromycin and hydroxychloroquine. Eight days after symptom onset, the patient had a rapid decline with increasing respiratory distress requiring intubation and transfer to the intensive care unit. At transfer, D-dimer (1782 ng/mL) and fibrinogen (606 mg/dL) levels were elevated. These markers peaked several days later: D-dimer > 10,000 ng/mL and fibrinogen > 1000 mg/dL. She was also placed on intravenous heparin (therapeutic dosing), given the elevated levels of D-dimer. During the patient's intensive care unit stay, she required hemodialysis for her acute kidney injury, which was thought secondary to the COVID-19 infection. After reduction in sedation on hospital day 19, right-sided weakness was noted and a noncontrast head CT was obtained. This scan demonstrated hypodensities within the left parietotemporal region, as well as a more unusual hypodensity within the corpus callosum (Fig 1).

FIG 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG 1.

Initial noncontrast head CT images demonstrate hypodensities in the left posterior parietal (black arrows) and peritrigonal regions as well as the corpus collosum (white arrows). No evidence of hemorrhage, mass effect, or midline shift is seen at this time.

Despite an overall improvement in the patient's respiratory status, extubation was delayed secondary to decreased mentation. On hospital day 27, an electroencephalography was performed, which demonstrated a triphasic morphology, most consistent with toxic encephalopathy with no evidence of epileptiform discharges. At that time, the patient was lethargic and aphasic with a poor prognosis for functional neurologic recovery. Subsequent noncontrast head CTs demonstrated areas of hemorrhage within the regions of hypodensity seen on the initial scan (Fig 2). The IV heparin was discontinued. The patient's mental status slowly improved with spontaneous eye opening/tracking and movement of the left extremities, though she remained aphasic. Secondary to improved mental status, the patient was eventually extubated.

FIG 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG 2.

Subsequent head CT demonstrates hemorrhage (white arrows) within the previously seen hypodensities. The posterior corpus collosum is involved.

Brain MR imaging obtained on hospital day 36 demonstrated multiple areas of diffusion restriction within the corpus callosum, corona radiata, and centrum semiovale, with associated T2-FLAIR hyperintensities. Multiple areas of microhemorrhage were also detected (Figs 3 and 4). The thalami, brain stem, and cerebellum were spared. At the time of this writing, the patient is receiving continued inpatient treatment.

FIG 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG 3.

Multiple diffusion-weighted images demonstrate restriction centered in the corpus collosum (white arrows), with some additional areas in the adjacent deep white matter including the centrum semiovale. In addition, there is faint diffusion restriction in the left occipital and temporal lobes, possibly representing subacute strokes. The thalami, brain stem, and cerebellum are spared.

FIG 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG 4.

A, Sagittal T1. Hypointense signal within the corpus collosum, most prominent in the splenium. B, Axial T2* sequence. Multiple punctate hypointensities compatible with hemorrhages are present within the corpus collosum (white arrow) and optic radiations, which are not shown. Axial (C) and coronal (D) T2 FLAIR. Increased T2 signal is seen with the corpus callosum (black arrows).

DISCUSSION

There appear to be multiple mechanisms for SARS-CoV-2 to cause neurologic damage, including direct neuronal injury, hypoxic damage from unresolved respiratory distress, autoimmune injury from the induced cytokine storm with resultant blood-brain barrier breakdown, vasculitis, and acute ischemic injury from a hypercoagulable state.1⇓⇓⇓-5 A recent case report described acute necrotizing encephalopathy,4 a condition well-described in children from a multitude of causes.4,5 In these cases, the predominant findings are located in the thalami, with additional less common locations being the brain stem, cerebral white matter, and cerebellum.4 In contrast, our patient demonstrated extensive diffusion restriction within the corpus callosum (most severe in the splenium) without involvement of the thalami, brain stem, or cerebellum.

One entity that has a similar appearance is a condition called cytotoxic lesions of the corpus callosum (CLOCC).6 These have been described with several pathologies, including drug-associated conditions, trauma, malignancy, metabolic disorders, and, most importantly, infection, including several viruses such as adenovirus, H1N1 influenza, Epstein-Barr, and rotavirus.6 When cytokine release and inflammation are present in sufficient levels within the brain, astrocytes are stimulated to release glutamate as well as block the reuptake of this neurotransmitter.6⇓-8 The greatly increased amount of glutamate within the extracellular space leads to excitotoxic action on multiple glutamate receptors, sodium-potassium pumps, and aquaporins, resulting in an influx of water trapped within the cells.6,9⇓-11 These effects manifest on imaging as diffusion restriction, as seen in our patient.6

It is believed that the corpus callosum is vulnerable to cytokine-induced injury due to the high density of cytokine, glutamate, and other receptors present within this region of the brain, particularly the splenium.6,12⇓⇓⇓⇓-17 These previously described mechanisms combined with our patient's extremely elevated markers for acute-phase reactants, suggest initial autoimmune injury from a cytokine storm. With other infectious diseases, the involvement of the corpus callosum is typically transitory; however, in the setting of COVID-19, this has yet to be determined.6,16 The patient also had ischemic changes in other parts of the brain, and an alternative consideration is a stroke of the corpus callosum. However, the redundant blood supply to the corpus callosum, including the anterior communicating artery, the pericallosal artery, and the posterior pericallosal artery, makes strokes of the corpus callosum rare.18 The subsequent hemorrhage in these areas is likely multifactorial, with evolution of necrosis from a cytokine storm being a possible contributing factor. While the use of therapeutic-dose heparin was initially shown to improve patient mortality,19 this medication could also have played a role.

CONCLUSIONS

There is currently limited literature on the neuroimaging findings in COVID-19. To our knowledge, involvement of the corpus callosum related to the cytokine storm has not yet been described with this infection. While as of yet, the transitory nature of this complication is unknown, the authors believe that with continued surveillance, this question is likely to be answered. As management is directed to the cytokine storm, knowledge of this imaging pattern could be invaluable.

Footnotes

  • Disclosures: Anant Krishnan—UNRELATED: Expert Testimony: Various.

Indicates open access to non-subscribers at www.ajnr.org

References

  1. 1.↵
    1. Wu Y,
    2. Xu X,
    3. Chen Z, et al
    . Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18–22 doi:10.1016/j.bbi.2020.03.031 pmid:32240762
    CrossRefPubMed
  2. 2.↵
    1. Li YC,
    2. Bai WZ,
    3. Hashikawa T
    . The neuroinvasive potential of SARS-COV-2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92;552–55 doi:10.1002/jmv.25728 pmid:32104915
    CrossRefPubMed
  3. 3.↵
    1. Chen T,
    2. Wu D,
    3. Chen H, et al
    . Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020;368:m1091 doi:10.1136/bmj.m1091 pmid:32217556
    Abstract/FREE Full Text
  4. 4.↵
    1. Poyiadji N,
    2. Shahin G,
    3. Noujaim D, et al
    . COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 2020 Mar 31. [Epub ahead of print] doi:10.1148/radiol.2020201187 pmid:32228363
    CrossRefPubMed
  5. 5.↵
    1. Rossi A
    . Imaging of acute disseminated encephalomyelitis. Neuroimaging Clin N Am 2008;18:149–61 doi:10.1016/j.nic.2007.12.007 pmid:18319160
    CrossRefPubMed
  6. 6.↵
    1. Starkey J,
    2. Kobayashi N,
    3. Numaguchi Y, et al
    . Cytotoxic lesions of the corpus callosum that show restricted diffusion: mechanisms, causes, and manifestations. Radiographics 2017;37:562–76 doi:10.1148/rg.2017160085 pmid:28165876
    CrossRefPubMed
  7. 7.↵
    1. Miller AH,
    2. Haroon E,
    3. Raison CL, et al
    . Cytokine targets in the brain: impact on neurotransmitter and neurocircuits. Depress Anxiety 2013;30:297–306 doi:10.1002/da.22084 pmid:23468190
    CrossRefPubMed
  8. 8.↵
    1. Phelps C,
    2. Korneva E, et al
    . Neuroimmune biology. Cytokines and the Brain. Vol 6. Elsevier; 2008:295–98
  9. 9.↵
    1. Leonoudakis D,
    2. Braithwaite SP,
    3. Beattie MS, et al
    . TNFa-induced AMPA-receptor trafficking in CNS neurons: relevance to excitotoxicity? Neuron Glia Biol 2004;1:263–73 doi:10.1017/S1740925X05000608 pmid:16520832
    CrossRefPubMed
  10. 10.↵
    1. Prow NA,
    2. Irani DN
    . The inflammatory cytokine, interleukin-1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis. J Neurochem 2008;105:1276–86 doi:10.1111/j.1471-4159.2008.05230.x pmid:18194440
    CrossRefPubMed
  11. 11.↵
    1. Matute C,
    2. Alberdi E,
    3. Domercq M, et al
    . Excitotoxic damage to white matter. J Anat 2007;210:693–702 doi:10.1111/j.1469-7580.2007.00733.x pmid:17504270
    CrossRefPubMed
  12. 12.↵
    1. Hassel B,
    2. Boldingh KA,
    3. Narvesen C, et al
    . Glutamate transport, glutamate synthetase and phosphate-activated glutaminase in rat CNS white matter: a quantitative study. J Neurochem 2003;87:230–37 doi:10.1046/j.1471-4159.2003.01984.x pmid:12969269
    CrossRefPubMed
  13. 13.↵
    1. Domercq M,
    2. Matute C
    . Expression of glutamate transporters in adult bovine corpus callosum. Brain Res Mol Brain Res 1999;67:296–302 doi:10.1016/S0169-328X(99)00072-8 pmid:10216228
    CrossRefPubMed
  14. 14.↵
    1. Goursaud S,
    2. Kozlova EN,
    3. Maloteaux J-M, et al
    . Cultured astrocytes derived from corpus callosum or cortical grey matter show distinct glutamate handling properties. J Neurochem 2009;108:1442–52 doi:10.1111/j.1471-4159.2009.05889.x pmid:19222709
    CrossRefPubMed
  15. 15.↵
    1. Moritani T,
    2. Smoker WR,
    3. Sato Y, et al
    . Diffusion-weighted imaging of acute excitotoxic brain injury. AJNR Am J Neuroradiology 2005;26:216–28 pmid:15709116
    FREE Full Text
  16. 16.↵
    1. Takayama H,
    2. Kobayashi M,
    3. Sugishita M, et al
    . Diffusion-weighted imaging demonstrates transient cytotoxic edema involving the corpus callosum in a patient with diffuse brain injury. Clin Neurol Neurosurg 2000;102:135–39 doi:10.1016/S0303-8467(00)00079-2 pmid:10996710
    CrossRefPubMed
  17. 17.↵
    1. Kimura EN,
    2. Okamoto S,
    3. Uchida Y, et al
    . A reversible lesion of the corpus callosum splenium with adult influenza-associated encephalitis/encephalopathy: a case report. J Med Case Rep 2008;2:220 doi:10.1186/1752-1947-2-220 pmid:18588700
    CrossRefPubMed
  18. 18.↵
    1. Yang LI,
    2. Huang YN,
    3. Cui ZT
    . Clinical features of acute corpus callosum infarction patients. Int J Clin Exp Pathol 2014;7:5160–64 pmid:25197390
    PubMed
  19. 19.↵
    1. Tang N,
    2. Bai H,
    3. Chen X, et al
    . Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020;18:1094–99 doi:10.1111/jth.14817 pmid:32220112
    CrossRefPubMed
  • Received May 29, 2020.
  • Accepted after revision June 3, 2020.
  • © 2020 by American Journal of Neuroradiology
View Abstract
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 41 (9)
American Journal of Neuroradiology
Vol. 41, Issue 9
1 Sep 2020
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 and Involvement of the Corpus Callosum: Potential Effect of the Cytokine Storm?
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
C. Rasmussen, I. Niculescu, S. Patel, A. Krishnan
COVID-19 and Involvement of the Corpus Callosum: Potential Effect of the Cytokine Storm?
American Journal of Neuroradiology Sep 2020, 41 (9) 1625-1628; DOI: 10.3174/ajnr.A6680

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
COVID-19 and Involvement of the Corpus Callosum: Potential Effect of the Cytokine Storm?
C. Rasmussen, I. Niculescu, S. Patel, A. Krishnan
American Journal of Neuroradiology Sep 2020, 41 (9) 1625-1628; DOI: 10.3174/ajnr.A6680
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABBREVIATIONS:
    • DISCUSSION
    • CONCLUSIONS
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref (8)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • COVID-19-Associated Neurological Manifestations: An Emerging Electroencephalographic Literature
    Geoffroy Vellieux, Romain Sonneville, Sérafima Vledouts, Pierre Jaquet, Anny Rouvel-Tallec, Marie-Pia d’Ortho
    Frontiers in Physiology 2021 11
  • Brain microstructure and connectivity in COVID-19 patients with olfactory or cognitive impairment
    Alberto Arrigoni, Mattia Previtali, Sara Bosticardo, Giulio Pezzetti, Sofia Poloni, Serena Capelli, Angela Napolitano, Andrea Remuzzi, Rosalia Zangari, Ferdinando Luca Lorini, Maria Sessa, Alessandro Daducci, Anna Caroli, Simonetta Gerevini
    NeuroImage: Clinical 2024 43
  • Relevance of CSF, Serum and Neuroimaging Markers in CNS and PNS Manifestation in COVID-19: A Systematic Review of Case Report and Case Series
    Sanjiti Podury, Samiksha Srivastava, Erum Khan, Mihir Kakara, Medha Tandon, Ashish K. Shrestha, Kerri Freeland, Sijin Wen, Shitiz Sriwastava
    Brain Sciences 2021 11 10
  • Letter by Dhillon and Lenthall Regarding Article, “Infarction of the Splenium of the Corpus Callosum in the Age of COVID-19: A Snapshot in Time”
    Permesh Singh Dhillon, Robert Lenthall
    Stroke 2020 51 12
  • Response by Sparr and Bieri to Letter Regarding Article, “Infarction of the Splenium of the Corpus Callosum in the Age of COVID-19: A Snapshot in Time”
    Steven A. Sparr, Phyllis Bieri
    Stroke 2020 51 12
  • Impaired lung function in multiple sclerosis: a single-center observational study in 371 persons
    Iván Murrieta-Álvarez, José A. Fernández-Gutiérrez, Carlos A. Pérez, Andrés A. León-Peña, Óscar A. Reyes-Cisneros, José M. Benítez-Salazar, Daniela Sánchez-Bonilla, Juan C. Olivares-Gazca, Danitza Fernández-Lara, Rogelio Pérez-Padilla, Guillermo J. Ruiz-Delgado, Guillermo J. Ruiz-Argüelles
    Neurological Sciences 2023 44 12
  • Atypical Cytotoxic Lesion and Hemorrhagic Involvement of the Corpus Callosum in Severe COVID-19 Infection
    Angela Guarnizo-Capera, Manuela Gallo Tapias, José David Cardona Ortegón, Valentina Ferrer Valencia
    Current Medical Imaging Reviews 2023 20
  • „Reversible splenial lesion syndrome“ (RESLES) nach einer mild verlaufenden SARS-CoV-2-Infektion
    R. Hermann, Z. Acimov, G. Gavrilovs, C. Klötzsch
    DGNeurologie 2021 4 6

More in this TOC Section

  • Diagnostic Neuroradiology of Monoclonal Antibodies
  • Clinical Outcomes After Chiari I Decompression
  • Segmentation of Brain Metastases with BLAST
Show more Adult Brain

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

Special Collections

  • AJNR Awards
  • ASNR Foundation Special Collection
  • Most Impactful AJNR Articles
  • Photon-Counting CT
  • Spinal CSF Leak Articles (Jan 2020-June 2024)

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire